usually most pronounced during dose escalation Diarrhea : Affects 12-17% of patients, typically mild to moderate in severity Vomiting : Reported in 6-10% of patients, more common at higher doses Constipation : Occurs in 6-11% of patients Abdominal pain and dyspepsia : Generally transient Decreased appetite : An expected pharmacological effect contributing to weight loss Other documented adverse effects include injection site reactions, hypoglycemia (when used with insulin or sulfonylureas), and less commonly, fatigue
Pharmacokinetics, safety and tolerability of Melissa officinalis extract which contained rosmarinic acid in healthy individuals: a randomized controlled trial
Plan your protocol so vial supply aligns with intended cycle duration
The most common side effects of both drugs are gastrointestinal ones, like nausea, diarrhea, vomiting, constipation, abdominal pain, and others
To be eligible, you must have commercial insurance with coverage for Wegovy and a valid prescription for Wegovy
Weeks 5 to 8: This is where momentum builds